Barometer Capital Management Inc. reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.1% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 9,487 shares of the pharmaceutical company’s stock after selling 3,342 shares during the period. Vertex Pharmaceuticals makes up approximately 1.2% […]
Washington Trust Bank cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the period. Vertex Pharmaceuticals comprises approximately 1.3% of Washington Trust […]
Washington Trust Bank lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the quarter. Vertex Pharmaceuticals comprises approximately 1.3% of […]
Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […]
Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […]